XML 48 R27.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis
The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):
March 31, 2023Level 1Level 2Level 3Total
Assets    
Cash equivalents$9.0 $— $— $9.0 
Available-for-sale investments:
Corporate debt securities
— 910.0 — 910.0 
Asset-backed securities
— 293.0 — 293.0 
United States government and agency securities53.1 50.6 — 103.7 
Municipal securities
— 2.6 — 2.6 
Investments held for deferred compensation plans117.8 — — 117.8 
Derivatives— 51.7 — 51.7 
$179.9 $1,307.9 $— $1,487.8 
Liabilities    
Derivatives$— $23.4 $— $23.4 
Contingent consideration liabilities— — 26.9 26.9 
Other liability— — 14.0 14.0 
$— $23.4 $40.9 $64.3 
December 31, 2022    
Assets    
Cash equivalents$0.4 $— $— $0.4 
Available-for-sale investments:
Corporate debt securities
— 980.3 — 980.3 
Asset-backed securities
— 366.6 — 366.6 
United States government and agency securities37.1 94.5 — 131.6 
Municipal securities
— 2.5 — 2.5 
Investments held for deferred compensation plans112.1 — — 112.1 
Derivatives— 65.5 — 65.5 
$149.6 $1,509.4 $— $1,659.0 
Liabilities    
Derivatives$— $27.2 $— $27.2 
Contingent consideration liabilities— — 26.2 26.2 
Other liability— — 14.0 14.0 
$— $27.2 $40.2 $67.4 
Schedule of Changes in Fair Value of Contingent Consideration Obligation The following tables summarize the changes in fair value of the contingent consideration and the other liability (in millions):
 Contingent ConsiderationOther liabilityTotal
Balance at December 31, 2022
$26.2 $14.0 $40.2 
Changes in fair value0.7 — 0.7 
Balance at March 31, 2023$26.9 $14.0 $40.9 
Contingent ConsiderationOther liabilityTotal
Balance at December 31, 2021
$62.0 $14.0 $76.0 
Changes in fair value(2.9)— (2.9)
Balance at March 31, 2022$59.1 $14.0 $73.1